Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

A 7% decrease in the differential renal uptake of MAG3 implies a loss in renal function.

Taylor A, Manatunga A, Halkar R, Issa MM, Shenvi NV.

Urology. 2010 Dec;76(6):1512-6. doi: 10.1016/j.urology.2010.03.066. Epub 2010 Aug 13.

2.

Monitoring renal function: a prospective study comparing camera-based technetium-99m mercaptoacetyltriglycine clearance and creatinine clearance.

Halkar R, Taylor A, Manatunga A, Issa MM, Myrick SE, Grant S, Shenvi NV.

Urology. 2007 Mar;69(3):426-30.

3.

99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.

Esteves FP, Taylor A, Manatunga A, Folks RD, Krishnan M, Garcia EV.

AJR Am J Roentgenol. 2006 Dec;187(6):W610-7.

PMID:
17114514
4.

Kidney function after nephrectomy for renal cell carcinoma.

Shirasaki Y, Tsushima T, Saika T, Nasu Y, Kumon H.

Urology. 2004 Jul;64(1):43-7; discussion 48.

PMID:
15245931
5.

Differential renal function estimation by dynamic renal scintigraphy: influence of background definition and radiopharmaceutical.

Caglar M, Gedik GK, Karabulut E.

Nucl Med Commun. 2008 Nov;29(11):1002-5. doi: 10.1097/MNM.0b013e32830978af.

PMID:
18836380
6.

Re: Taylor et al.: a 7% decrease in the differential renal uptake of MAG3 implies a loss in renal function (Urology 2010;76:1512-1516).

Zuckier LS.

Urology. 2011 Apr;77(4):1011; author reply 1011-2. doi: 10.1016/j.urology.2010.12.063. No abstract available.

PMID:
21477735
7.

Evaluation of renal function with 99mTc-MAG3 using semiautomated regions of interest.

Inoue Y, Yoshikawa K, Yoshioka N, Watanabe T, Saegusa S, Kaneko Y, Yokoyama I, Ohtomo K.

J Nucl Med. 2000 Dec;41(12):1947-54.

8.

Renal uptakes of 99mTc-MAG3, 99mTc-DTPA, and 99mTc-DMSA in rabbits with unilateral ureteral obstruction.

Lee WG, Kim JH, Kim JM, Shim KM, Kang SS, Chae HI, Choi SH.

In Vivo. 2010 Mar-Apr;24(2):137-9.

PMID:
20363984
9.

Influence of hydration status in normal subjects: fractional analysis of parameters of Tc-99m DTPA and Tc-99m MAG3 renography.

Jung HS, Chung YA, Kim EN, Kim SH, Lee SY, Sohn HS, Park YH, Chung SK.

Ann Nucl Med. 2005 Feb;19(1):1-7.

PMID:
15770966
10.

A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.

Sohaib M, Rafique A, Saeed S, Afshan A.

Clin Physiol Funct Imaging. 2013 Sep;33(5):353-8. doi: 10.1111/cpf.12034. Epub 2013 Mar 18.

PMID:
23701132
12.

Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats.

Drost WT, McLoughlin MA, Mattoon JS, Lerche P, Samii VF, DiBartola SP, Chew DJ, Barthez PY.

Am J Vet Res. 2003 Sep;64(9):1076-80.

PMID:
13677382
13.

Diagnosis of kidney transplant obstruction using Mag3 diuretic renography.

Nankivell BJ, Cohn DA, Spicer ST, Evans SG, Chapman JR, Gruenewald SM.

Clin Transplant. 2001 Feb;15(1):11-8.

PMID:
11168310
14.

Relative 99mTc-MAG3 renal uptake: reproducibility and accuracy.

Piepsz A, Tondeur M, Ham H.

J Nucl Med. 1999 Jun;40(6):972-6.

15.

Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.

Hamscho N, Wilhelm A, Döbert N, Menzel C, Gossmann J, Berner U, Zaplatnikov K, Scheuermann EH, Grünwald F.

Nuklearmedizin. 2005;44(5):200-4.

PMID:
16395496
16.

Evaluation of renal function from 99mTc-MAG3 renography without blood sampling.

Inoue Y, Ohtake T, Yokoyama I, Yoshikawa K, Asai S, Ohtomo K.

J Nucl Med. 1999 May;40(5):793-8.

17.

Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.

Aktaş A, Aras M, Colak T, Gençoğlu A, Karakayali H.

Transplant Proc. 2006 Mar;38(2):449-53.

PMID:
16549144
18.

Study on 99mTc-MAG3 and 99mTc-DMSA renal accumulation using in vitro cellular model.

Nový Z, Mandíková J, Trejtnar F.

Ceska Slov Farm. 2011 Feb;60(1):7-10.

PMID:
21648170
19.

Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function.

Erdil TY, Dede F, Tuglular S, Sen F, Ones T, Farsakoglu Z, Inanir S, Ozener C, Akoglu E, Turoglu T.

Nucl Med Commun. 2006 Feb;27(2):191-6.

PMID:
16404234
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk